GPT and metabolic syndrome: In addition, increased liver enzyme levels were also associated with higher risk of DM, hypertension, dyslipidemia, and metabolic syndrome in MASLD individuals, with an odds ratio ranging from 1.23 to 6.44 in comparison to individuals with normal AST and ALT values without steatotic liver disease (all p values below 0.001).